Exagen Inc.XGNNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank92
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-17.95%
↑ 60% vs avg
Percentile
P92
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-44.34%
Historical baseline
PeriodValueYoY Change
TTM-17.95%+10.4%
2024-20.03%+45.0%
2023-36.45%+62.0%
2022-95.83%-100.3%
2021-47.83%-47.0%
2020-32.53%-65.7%
2019-19.64%-46.3%
2018-13.42%+84.0%
2017-84.16%-11.5%
2015-75.50%-